NASDAQ:IFRX - Nasdaq - NL0012661870 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 85% to IFRX. The Buy consensus is the weighted average rating of the current analysts ratings.
Date | Firm | Action | Rating |
---|---|---|---|
2025-01-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
2024-12-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
2024-11-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
2024-11-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
2024-09-25 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
2024-06-24 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
2024-06-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
2024-05-09 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
2024-03-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
2024-01-25 | HC Wainwright & Co. | Maintains | Buy -> Buy |
2023-11-02 | Raymond James | Maintains | Strong Buy -> Strong Buy |
2023-09-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
2023-08-31 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
2023-08-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
2023-05-12 | Raymond James | Maintains | Strong Buy -> Strong Buy |
2023-05-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
2023-04-21 | HC Wainwright & Co. | Maintains | Buy |
2023-04-06 | Raymond James | Maintains | Strong Buy |
2023-04-05 | LifeSci Capital | Upgrade | Market Perform -> Outperform |
2023-04-05 | Guggenheim | Upgrade | Neutral -> Buy |
2023-04-05 | HC Wainwright & Co. | Reiterate | Buy |
2023-03-23 | HC Wainwright & Co. | Reiterate | Buy |
2023-01-06 | HC Wainwright & Co. | Maintains | Buy |
2022-11-10 | Raymond James | Maintains | Strong Buy |
2022-08-08 | HC Wainwright & Co. | Maintains | Buy |
2022-05-13 | Raymond James | Maintains | Strong Buy |
2022-05-13 | Credit Suisse | Maintains | Underperform |
2022-05-13 | HC Wainwright & Co. | Maintains | Buy |
2022-05-12 | SVB Leerink | Maintains | Outperform |
2021-11-08 | Raymond James | Maintains | Strong Buy |